Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase. - Wikidata - awgldk - TriplyDB

Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase.

Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase.

http://www.wikidata.org/entity/Q47303802

about

Preconditioning for traumatic brain injury Anaesthetics as cardioprotectants: translatability and mechanism Opioid-induced cardioprotection Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology Lidocaine Enhances Contractile Function of Ischemic Myocardial Regions in Mouse Model of Sustained Myocardial Ischemia Peri-operative anaesthetic myocardial preconditioning and protection - cellular mechanisms and clinical relevance in cardiac anaesthesia Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury A new approach to selective brain cooling by a Ranque-Hilsch vortex tube Subcellular Energetics and Metabolism: Potential Therapeutic Applications.A novel mechanism for sevoflurane preconditioning-induced neuroprotection.Physiology and pharmacology of myocardial preconditioning and postconditioning.Physiology and pharmacology of myocardial preconditioning.The use of a volatile anesthetic regimen protects against acute normovolemic hemodilution induced myocardial depression in patients with coronary artery disease.Neuroprotection provided by isoflurane pre-conditioning and post-conditioning Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue.Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection.Effect of remote ischemic conditioning on atrial fibrillation and outcome after coronary artery bypass grafting (RICO-trial).KATP channel blocker does not abolish the protective effect of Na+/H+ exchange 1 inhibition against ischaemia/reperfusion in aged myocardium.Signaling epicenters: the role of caveolae and caveolins in volatile anesthetic induced cardiac protection.Mitochondrial depolarization underlies delay in permeability transition by preconditioning with isoflurane: roles of ROS and Ca2+.Mitochondrial targets for volatile anesthetics against cardiac ischemia-reperfusion injury Effect of fetal anaemia on myocardial ischaemia-reperfusion injury and coronary vasoreactivity in adult sheep Adenosine receptor regulation of coronary blood flow in Ossabaw miniature swine Cardioprotective trafficking of caveolin to mitochondria is Gi-protein dependent.Delayed anesthetic preconditioning protects against myocardial infarction via activation of nuclear factor-κB and upregulation of autophagy.Isoflurane and coronary heart disease.Preconditioning - endogenous defence mechanisms of the heart.Isoflurane preconditioning confers cardioprotection by activation of ALDH2.Emulsified isoflurane preconditioning reduces lung injury induced by hepatic ischemia/reperfusion in rats.Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolins Up-regulation of microRNA-21 mediates isoflurane-induced protection of cardiomyocytes.Use of a hanging weight system for coronary artery occlusion in mice.Isoflurane protects against human endothelial cell apoptosis by inducing sphingosine kinase-1 via ERK MAPK.MicroRNA-21 Mediates Isoflurane-induced Cardioprotection against Ischemia-Reperfusion Injury via Akt/Nitric Oxide Synthase/Mitochondrial Permeability Transition Pore Pathway Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside?Isoflurane differentially modulates mitochondrial reactive oxygen species production via forward versus reverse electron transport flow: implications for preconditioning Endothelial-cardiomyocyte crosstalk enhances pharmacological cardioprotection.Caveolin as a potential drug target for cardiovascular protection.Perioperative elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: a randomised-controlled trial Marked hyperglycemia attenuates anesthetic preconditioning in human-induced pluripotent stem cell-derived cardiomyocytes.

P2860

Q26830665-55160863-94D0-4436-974C-F1F02E3EF341 Q26863637-E69E86FD-1F8B-4734-AA5F-51425C1867A9 Q27006830-A6F46673-897D-44FB-B3A8-8E636A8928C4 Q27009399-1B60BFAA-8235-4C5E-905C-2535396AC8ED Q27348829-B3BDCB47-A4CE-4F86-A3EB-C750AEC56FEC Q28085567-1943EFFA-A18A-4FCA-9898-58A4C415AAF6 Q28580280-5B64673C-5AEB-4717-B81D-9251826B8325 Q28828408-DBE8DC58-16E9-41B3-AE46-BEC35EDD753D Q30253000-A1B3564A-2A54-4840-AA2B-BD620E71B88F Q30416485-9B2EEE09-06B8-4EA7-8C26-C2DA5D534854 Q30448088-F1CCE5E7-DA6B-4C0E-B39D-7F3966354336 Q30450862-E038A85E-62EF-4B66-89A9-025B4C9E9CA1 Q33560030-401EB94D-50CE-4B88-90A0-DC17584A4C52 Q33594536-25564C30-F3F6-4D40-90E3-39EB7FDF6075 Q33629823-FFE2437F-4937-4623-972B-22BFBEF140B5 Q33814419-00DEC469-7D59-48CD-907B-A383C8F0DE63 Q33909487-2584F469-3FD1-44BE-807E-5E82F6D20077 Q33976641-6032CC3F-5AA2-43E8-8522-E702455307CB Q33993790-4836C925-A397-4023-8C82-AD045DBBF546 Q34085718-4B8E7F83-4359-452D-A81B-1B286BBFBBC6 Q34193073-A7F4D4A5-0CC6-423C-94E8-CB636F17FE97 Q34267673-82B45BEF-3999-4E5E-A8CC-7C362EDCA121 Q34359947-07F742AC-1F20-4C27-821B-1B369DB4B9C0 Q34449891-2868AB40-C3E2-43CD-A5A8-8A86EFC6FC8C Q34473304-1A66DE36-8A42-478A-9FBA-F88053A9BC33 Q34592237-6FBD1230-27ED-4CB6-B0F8-217428D7822A Q34593774-936035DD-A64E-4298-A337-ABB5513B53C4 Q34611312-8EC50681-0E52-429F-884B-20093359EEFE Q35057911-9A370BA1-E3AF-489C-ABFE-9354739BEE7E Q35183060-EA9CC476-78E3-4769-8383-C2DDF017D195 Q35196236-C0AE1531-0A12-401C-92A0-435DC8151438 Q35203103-FAD7C2DB-2ECC-4CB9-9944-47476B63247A Q35719530-583B354D-C8C6-4800-9646-8CD755C8DA40 Q35741573-9444A9BF-783B-4AEE-87BA-90A6AE09BE9D Q35741598-0FDA4C14-E8E3-4C52-97FF-E3621F450228 Q35915777-DC9686CD-042C-4DC1-AC1E-4EF97E55AD4F Q35928926-26074393-15AA-460B-A186-463A8CF23DF5 Q36193737-B8DE7683-B478-413D-B424-22488BE7C925 Q36209021-DFA4E011-4115-4710-B3D4-DF03FD3D0377 Q36283727-A5FA513B-1F37-4246-BAA5-2DF080F6766F

P2860

Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase.

http://www.wikidata.org/entity/Q47303802

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh-hant

name

Isoflurane mimics ischemic preconditioning via activation of K

@nl

Isoflurane mimics ischemic pre ...... ze with an acute memory phase.

@en

type

label

Isoflurane mimics ischemic preconditioning via activation of K

@nl

Isoflurane mimics ischemic pre ...... ze with an acute memory phase.

@en

prefLabel

Isoflurane mimics ischemic preconditioning via activation of K

@nl

Isoflurane mimics ischemic pre ...... ze with an acute memory phase.

@en

P1433

Q47303802-0ECCF603-7DAE-4C39-8569-B1E47DC0A33C

P1476

Q47303802-FD97F869-A25E-410F-BC0D-25F47AC099EB

P2093

Q47303802-054F7B06-C51E-4FAC-883C-5FA9E44B612B

Q47303802-2FA89D4A-0FA3-4668-9EBF-DC0659BD680B

Q47303802-759F9BE4-6BCE-4326-8D89-99D5B7282EE8

Q47303802-A02105E6-09AE-4E7B-8477-B8676428C7C5

Q47303802-F85E01AE-863E-449A-B063-555EA2330803

P304

Q47303802-324A3BD9-A27C-4466-BB06-B6B37424EC4D

P31

Q47303802-7511085F-B4F6-42B0-A993-897AEF6E31E5

P356

Q47303802-2A562220-1B60-4F2D-849D-95892C7867C4

P407

Q47303802-76FE79A4-8FE4-4E85-AEC8-E20D44EFFC4D

P433

Q47303802-37CC6A36-3DBD-40D3-B490-FCFB4AA92264

P478

Q47303802-37E49C16-D311-4CA7-B791-50A6B4E18E6C

P577

Q47303802-BE90ED49-9B9E-4D2F-B378-DCBABEEAA345

P698

Q47303802-C92105F7-61E1-45BD-8A70-900F722E2A55

P356

00000542-199708000-00024

P1433

P1476

Isoflurane mimics ischemic pre ...... ze with an acute memory phase.

@en

P2093

Gross GJ

http://www.w3.org/2001/XMLSchema#string

Kersten JR

http://www.w3.org/2001/XMLSchema#string

Pagel PS

http://www.w3.org/2001/XMLSchema#string

Schmeling TJ

http://www.w3.org/2001/XMLSchema#string

Warltier DC

http://www.w3.org/2001/XMLSchema#string

P304

361-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00000542-199708000-00024

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

1997-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9286901

http://www.w3.org/2001/XMLSchema#string